News
- Home
- News
Featured News
Innovative Hematology, home to the Indiana Hemophilia & Thrombosis Center (IHTC), announces the launch of its Gene Therapy Hub—Indiana’s only comprehensive center providing on-site gene therapy for hemophilia.
Recent News
Protecting patients and staff is an important part of our mission. Please follow these guidelines at IHI to reduce the spread of illness.
Dr. Magdalena Lewandowska is running her first New York City Marathon to raise money for the National Bleeding Disorders Foundation.
The future of ITP treatment is bright, with new therapeutic targets and measures.
Bleeding Disorders: What You Need to Know
For most kids, playground bumps and bruises are no big deal. But for kids with a bleeding disorder like hemophilia or von Willebrand disease (VWD), these injuries—especially to the head—could be an emergency.
Innovative Hematology achieves prestigious HHT Center of Excellence certification
We are thrilled to share that Innovative Hematology, home to the Indiana Hemophilia and Thrombosis Center (IHTC), has officially earned the coveted designation as an HHT Center of Excellence by Cure HHT. This marks another significant step forward in our fight to...
Sickle cell event aims to get attention of Indiana lawmakers
Members of the Indiana General Assembly are hearing a unified call for help as they return to the statehouse Monday. The Sickle Cell Awareness Day event aims to fill the building with messages about the problems many people with sickle cell face to alert lawmakers to ways the state can help.
Respiratory Virus Guidance
The following guidelines remain in place at Innovative Hematology to reduce the spread of illness for patients and caregivers.
Introducing Innovative Hematology/IHTC’s Cardiovascular Disease (CVD) Risk Reduction Program
Innovative Hematology and the Indiana Hemophilia & Thrombosis Center (IHTC) are excited to announce our new Cardiovascular Disease Risk Reduction Program. Cardiovascular disease (CVD) is also known as heart disease. The goal of this program is to reduce patients’ risk of CVD.
Man first in Indiana to receive gene therapy for hemophilia B
A 42-year-old man made history as the first person in Indiana to undergo gene therapy for hemophilia B at Innovative Hematology.
Indiana team of blood disorder experts host education camp in Kenya
Innovative Hematology host an annual camp for Indiana kids with hemophilia and partnered with a clinic in Kenya to offer a similar program.
Innovative Hematology providers named ‘Top Docs’
Indianapolis Monthly’s 2024 Top Doctors issue has hit newsstands, with several of our physicians named among Central Indiana’s best.
The Most Common Bleeding Disorder in Your Patients Could be Hiding in Plain Sight
von Willebrand disease (VWD) is believed to be the most common bleeding disorder, affecting as many as 1% of the general population, yet is commonly left undiagnosed. Lifespan care is necessary, as prolonged uncontrolled bleeding can be life-threatening.
Partners Physician Academy
Drawing more doctors to rare, specialized care Like most industries, healthcare is experiencing a shortage of specialized doctors. In the hematology/oncology specialization, many physicians choose the more common of the two, oncology. Doctors who are trained in both...